MARCHI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 16.021
Totale 16.021
Nazione #
IT - Italia 16.021
Totale 16.021
Città #
Genova 12.860
Rapallo 1.889
Genoa 1.231
Bordighera 41
Totale 16.021
Nome #
Dangerous liaisons between beta-amyloid and cholinergic neurotransmission 144
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens nerve terminals 142
Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F 140
Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes 139
Presynaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms 132
Functional interaction between presynaptic nicotinic and D2 receptors on dopaminergic nerve endings of rat and mouse nucleus accumbens 132
INTRACEREBRAL ADMINISTRATION OF L-KYNURENINE DECREASES N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED PRODUCTION OF cGMP IN THE CEREBELLUM AND HIPPOCAMPUS OF UNANAESTHETIZED RATS SUBJECTED TO TRANSCEREBRAL MICRODIALYSIS 131
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in rat hippocampus 131
Presynaptic receptors modulating transmitter release: physiological and pharmacological aspects 128
Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training. 128
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 127
Salvinorin A modulates the neurotransmitters release from different mouse brain areas through presynaptic metabotropic receptors activation. 126
GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion 125
Aß influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 125
The activation of phosphatidylinositol turnover is not directly involved in the modulation of neurotransmitter release mediated by presynaptic muscarinic receptors 123
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 123
Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release 120
Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine 120
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus 119
Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during development 119
3H-thymidine long survival autoradiography as a method for dating the time of neuronal origin in the chick embryo; the locus coeruleus and cerebellar Purkinje cells 118
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 118
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system 118
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors 116
CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings 116
Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of phosphoinositide turnover in rat cerebral cortex 115
Presynaptic receptors as potential targets of psychotropic drugs 114
Role of external and internal calcium on heterocarrier-mediated transmitter release 112
Studies on a possible functional coupling between presynaptic acetylcholinesterase and high-affinity choline uptake in the rat brain 111
Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration 111
[3H]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway 111
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes 110
Dual Effect of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus 110
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 110
Effects of some rigid analogues of imipramine and amitriptyline on the uptake of noradrenaline, serotonin and choline in rat brain synaptosomes 109
Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat 109
Adaptation of presynaptic acetylcholine autoreceptors following long-term drug treatment 108
Presynaptic regulation of acetylcholine release in the CNS 108
Sustainable production of biologically active molecules of marine based origin 108
Acute β-Amyloid Administration Disrupts the Cholinergic Control of Dopamine Release in the Nucleus Accumbens 108
Facilitation of [3H]acetylcholine and [3H]5-hydroxytryptamine release from rat cerebral cortex synaptosomes by a factor extracted from the skin of the Australian frog Pseudophryne coriacea 106
Release of catecholamines, serotonin and acetylcholine from isolated brain tissue 106
Development and aging of noradrenergic cell bodies and axon terminals in the chicken 106
Nicotinic receptors modulating ACh release in rat cortical synaptosomes: role of Ca2+ ions in their function and desensitization 105
Beta Amyloid and cholinergic system: old actors for new different roles 105
Presynaptic nicotinic α7 and non-α7 receptors stimulate endogenous GABA release from rat hippocampal synaptosomes through two mechanisms of action. 105
Release-enhancing presynaptic muscarinic and nicotinic receptors coexist and interact on dopaminergic nerve endings of rat nucleus accumbens 105
Age-dependent changes in choline uptake of the chick iris 103
Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quasi-physiological" depolarization 103
Prolonged nicotine exposure down-regulates presynaptic \NMDA\ receptors in dopaminergic terminals of the rat nucleus accumbens 103
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals 103
< i> In vitro exposure to nicotine modulate the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 102
Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals 102
Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex 101
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 101
P2X7 receptors exert a permissive role on the activation of release- enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals 100
Modulation of endogenous and radiolabeled dopamine release by acetylcholine 100
Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors? 100
Presynaptic nicotinic receptors modulating neurotransmitter release in the Central Nervous System: functional interactions with other coexisting receptors 99
Dicyclomine- and pirenzepine-sensitive muscarinic receptors mediate inhibition of [3H]serotonin release in different rat brain areas 99
Intrastriatal kainic acid elicits functional supersensitivity of muscarinic receptors regulating dopamine release 99
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes 98
Cholinergic modulation of 3H-dopamine release from dendrosomes of rat substantia nigra 98
Evidence of the involvement of nitric oxide in the oxiracetam-induced potentiation of glutamate release in rat hippocampal slices 97
Norepinephrine levels in peripheral nerve terminals during development and aging 97
The functional recovery of damaged brain: the effect of GM1 monosialoganglioside 95
Stimulus-selective neuromodulatory action of beta-amyloid 95
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals 94
Muscarinic receptors mediating inhibition of GABA release in rat corpus striatum and their pharmacological characterization 93
Mechanisms underlying the modulation of dopamine release through presynaptic muscarinic receptors 93
5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2Ato mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis 92
Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release 91
Regulation of dopamine release by muscarinic receptors 91
Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex 91
Autoregulation of acetylcholine release in isolated hippocampal nerve endings 90
Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes 90
Modulation of sensitivity of central presynaptic autoreceptors 90
Neurotransmitter release as a functional test for the development of more selective CNS drugs 89
Age-dependent relationships among choline uptake, acetylcholine synthesis, acetylcholine release and muscarinic autoreceptors in rat brain synaptosomes 89
null 89
Heterogenenity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain 88
Dall'Arte degli Speziali alla Scienza del Farmaco a Genova 88
Presynaptic cholinergic mechanisms in human cerebral cortex of adult and aged patients 88
Changes of neurotransmitter release in the old rat brain and effects of phosphatidylserine treatment 85
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 85
Presynaptic modulation of cholinergic neurotransmission 85
Norepinephrine uptake in aging adrenergic nerve terminals 85
A new specific neuronal modulatory effect of nicotine: the functional cross talk between nicotinic and glutamate receptors 85
NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment 84
Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals 84
β-amyloid differently modulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 84
Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals 84
Increased uptake of [3H]choline by rat superior cervical ganglion: an effect of dexamethasone 84
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 84
Presynaptic muscarinic autoreceptors: changes of sensitivity during long-term drug treatment 83
Pharmacological characterization of the presynaptic muscarinic autoreceptors regulating acetylcholine release from rat cortical synaptosomes 83
Nicotinic and muscarinic cholinergic receptors coexist on GABAergic nerve endings in the mouse striatum and interact in modulating GABA release 82
The effect of long-term, oral treatment of rats with contraceptive steroids on tissue MAO 82
Pre-exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens synaptosomes 82
Study of the bidirectional transport of choline by blocking choline carriers from outside or inside brain nerve terminals 82
Totale 10.416
Categoria #
all - tutte 40.682
article - articoli 28.182
book - libri 0
conference - conferenze 7.012
curatela - curatele 183
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.305
Totale 81.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019649 0 0 0 0 0 0 0 0 0 0 360 289
2019/20204.427 179 99 215 220 392 386 634 233 380 845 619 225
2020/2021936 45 104 51 71 48 85 41 89 136 92 76 98
2021/20222.249 47 177 148 330 87 144 129 527 50 220 74 316
2022/20232.274 241 149 34 165 416 365 24 189 418 11 246 16
2023/2024895 51 146 28 144 100 232 38 55 53 44 4 0
Totale 16.167